{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:36:38Z","timestamp":1785782198303,"version":"3.56.0"},"reference-count":29,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2026-0016_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Inborn errors of metabolism (IEMs) are rare genetic disorders associated with increased vulnerability to infections and risk of metabolic decompensation. Although routine immunization is recommended, data on real-world vaccination status, seroprotection rates, and vaccine safety in children with IEMs remain limited. This study aimed to evaluate immunization status, antigen-specific seroprotection rates, determinants of seronegativity, and vaccine safety in a cohort of children with\u00a0IEMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0016_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single center cross-sectional study was conducted at a tertiary Pediatric Metabolism Unit of Eski\u015fehir Osmangazi University between January and June 2022. A total of 169 children were included. Vaccination history was obtained from immunization cards and parental report. Serological protection was assessed using commercial immunoassays and interpreted according to assay-specific cut-offs. Age eligibility and time since last vaccine dose were analyzed. Descriptive statistics were used to summarize immunization coverage and antibody levels. Group comparisons were performed using chi-square or Fisher\u2019s exact tests for categorical variables and non-parametric tests for continuous variables. A p-value &lt;0.05 was considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0016_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 169 pediatric patients (52.1\u202f% girls; mean age 65.8\u00a0\u00b1\u00a059.6\u00a0months) were assessed through medical record reviews and caregiver interviews, with serological testing for vaccine-preventable diseases conducted via standardized ELISA assays. Overall, 94\u202f% of children were vaccinated according to the national immunization program, and no vaccine-related metabolic decompensation or serious adverse events were observed. Six percent were unvaccinated or delayed, mainly due to hospitalization, neurological conditions, pandemic-related disruptions, or parental refusal. Only 9.5\u202f% had received non-scheduled vaccines. Seroprotection was high for tetanus (100\u202f%) and diphtheria (91.7\u202f%). Lower seroprotection was observed for hepatitis B (68.0\u202f%), hepatitis A (53.3\u202f%) and varicella (47.4\u202f%). However, seronegativity was strongly associated with longer time since last dose and age\u00a0ineligibility for routine vaccination, rather than clear evidence of disease-specific impaired vaccine response. Although numerical differences were observed across metabolic subgroups, no consistent pattern of impaired vaccine response attributable to IEM category was identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0016_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children with IEMs demonstrated high overall vaccination coverage and reassuring safety profiles when immunized during metabolically stable periods. Observed immunity gaps were largely explained by programmatic factors, age eligibility, and time since vaccination. These findings support systematic vaccination review and selective serological assessment within routine metabolic follow-up while avoiding overinterpretation of seronegativity as disease-specific immune insufficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2026-0016","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:59:57Z","timestamp":1778731197000},"page":"648-659","source":"Crossref","is-referenced-by-count":1,"title":["Are children with inborn errors of metabolism and cystic fibrosis adequately protected? Immunization status and seroepidemiological evaluation of vaccine-preventable diseases"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-667X","authenticated-orcid":false,"given":"Gonca","family":"K\u0131l\u0131\u00e7 Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[{"name":"Department of Pediatric Metabolism and Nutrition , Eskisehir Osmangazi University Faculty of Medicine , Eskisehir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8353-6796","authenticated-orcid":false,"given":"Meltem","family":"Dinleyici","sequence":"additional","affiliation":[{"name":"Department of Social Pediatrics , Eskisehir Osmangazi University Faculty of Medicine , Eskisehir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0168-4080","authenticated-orcid":false,"given":"\u00d6mer","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease , Eskisehir Osmangazi University Faculty of Medicine , Eskisehir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-0134","authenticated-orcid":false,"given":"Ener \u00c7a\u011fr\u0131","family":"Dinleyici","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Eskisehir Osmangazi University Faculty of Medicine , Eskisehir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2026070716574686928_j_jpem-2026-0016_ref_001","doi-asserted-by":"crossref","unstructured":"Vernon, HJ. Inborn errors of metabolism: advances in diagnosis and therapy. JAMA Pediatr 2015;169:778\u201382. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.0754.","DOI":"10.1001\/jamapediatrics.2015.0754"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_002","doi-asserted-by":"crossref","unstructured":"Agana, M, Frueh, J, Kamboj, M, Patel, DR, Kanungo, S. Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice. Ann Transl Med 2018;6:469. https:\/\/doi.org\/10.21037\/atm.2018.12.34.","DOI":"10.21037\/atm.2018.12.34"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_003","doi-asserted-by":"crossref","unstructured":"Ismail, IT, Showalter, MR, Fiehn, O. Inborn errors of metabolism in the era of untargeted metabolomics and lipidomics. Metabolites 2019;9:242. https:\/\/doi.org\/10.3390\/metabo9100242.","DOI":"10.3390\/metabo9100242"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_004","doi-asserted-by":"crossref","unstructured":"Sun, A, Lam, C, Wong, DA. Expanded newborn screening for inborn errors of metabolism: overview and outcomes. Adv Pediatr 2012;59:209\u201345. https:\/\/doi.org\/10.1016\/j.yapd.2012.04.013.","DOI":"10.1016\/j.yapd.2012.04.013"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_005","doi-asserted-by":"crossref","unstructured":"Aygen, S, D\u00fcrr, U, Hegele, P, Kunig, J, Spraul, M, Sch\u00e4fer, H, et al.. NMR-based screening for inborn errors of metabolism: initial results from a study on Turkish neonates. JIMD Rep 2014;16:101\u201311. https:\/\/doi.org\/10.1007\/8904_2014_326.","DOI":"10.1007\/8904_2014_326"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_006","doi-asserted-by":"crossref","unstructured":"Klein, NP, Aukes, L, Lee, J, Fireman, B, Shapira, SK, Slade, B, et al.. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics 2011;127:e1139\u201346. https:\/\/doi.org\/10.1542\/peds.2010-3706.","DOI":"10.1542\/peds.2010-3706"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_007","doi-asserted-by":"crossref","unstructured":"Tummolo, A, Melpignano, L. The reciprocal interplay between infections and inherited metabolic disorders. Microorganisms 2023;11:2545. https:\/\/doi.org\/10.3390\/microorganisms11102545.","DOI":"10.3390\/microorganisms11102545"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_008","doi-asserted-by":"crossref","unstructured":"de Boer, L, Cambi, A, Verhagen, LM, de Haas, P, van Karnebeek, CDM, Blau, N, et al.. Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects. Mol Genet Metabol 2023;139:107582. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107582.","DOI":"10.1016\/j.ymgme.2023.107582"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_009","doi-asserted-by":"crossref","unstructured":"Parvaneh, N, Quartier, P, Rostami, P, Casanova, JL, de Lonlay, P. Inborn errors of metabolism underlying primary immunodeficiencies. J\u00a0Clin Immunol 2014;34:753\u201371. https:\/\/doi.org\/10.1007\/s10875-014-0076-6.","DOI":"10.1007\/s10875-014-0076-6"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_010","doi-asserted-by":"crossref","unstructured":"Altun, I, Kiykim, A, Zubarioglu, T, Burtecene, N, Hopurcuoglu, D, Topcu, B, et al.. Altered immune response in organic acidemia. Pediatr Int 2022;64:e15082. https:\/\/doi.org\/10.1111\/ped.15082.","DOI":"10.1111\/ped.15082"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_011","doi-asserted-by":"crossref","unstructured":"G\u00fcm\u00fc\u015f, E, \u00d6zen, H. Glycogen storage diseases: an update. World J Gastroenterol 2023;29:3932\u201363. https:\/\/doi.org\/10.3748\/wjg.v29.i25.3932.","DOI":"10.3748\/wjg.v29.i25.3932"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_012","doi-asserted-by":"crossref","unstructured":"Hady-Cohen, R, Dragoumi, P, Barca, D, Plecko, B, Lerman-Sagie, T, Zafeiriou, D. Safety and recommendations for vaccinations of children with inborn errors of metabolism. Eur J Paediatr Neurol 2021;35:93\u20139. https:\/\/doi.org\/10.1016\/j.ejpn.2021.10.002.","DOI":"10.1016\/j.ejpn.2021.10.002"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_013","doi-asserted-by":"crossref","unstructured":"Ramos, BCF, Aranda, CS, Cardona, RSB, Martins, AM, Sol\u00e9, D, Clemens, SAC, et al.. Vaccination strategies for people living with inborn errors of metabolism in Brazil. J\u00a0Pediatr (Rio J) 2023;99:S70\u201380. https:\/\/doi.org\/10.1016\/j.jped.2022.12.001.","DOI":"10.1016\/j.jped.2022.12.001"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_014","doi-asserted-by":"crossref","unstructured":"Menni, F, Chiarelli, G, Sabatini, C, Principi, N, Esposito, S. Vaccination in children with inborn errors of metabolism. Vaccine 2012;30:7161\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.012.","DOI":"10.1016\/j.vaccine.2012.10.012"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_015","doi-asserted-by":"crossref","unstructured":"Renous, AS, Damaj, L, Gorce, M, Barth, M, Bedu, A, Sacaze, E, et al.. Immunization coverage and timeliness of vaccination in young patients with inborn errors of metabolism: a French multicentric study. Orphanet J Rare Dis 2025;20:149\u201359. https:\/\/doi.org\/10.1186\/s13023-025-03648-w.","DOI":"10.1186\/s13023-025-03648-w"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_016","doi-asserted-by":"crossref","unstructured":"Erdal, \u0130, Kahraman, AB, Y\u0131ld\u0131z, Y, Yal\u00e7\u0131n, SS. Newborn screening programs promote vaccine acceptance among parents in Turkey: a cross-sectional study. Postgrad Med J 2025;137:423\u201338. https:\/\/doi.org\/10.1080\/00325481.2025.2504866.","DOI":"10.1080\/00325481.2025.2504866"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_017","doi-asserted-by":"crossref","unstructured":"Cerutti, M, De Lonlay, P, Menni, F, Parini, R, Principi, N, Esposito, S. Vaccination coverage of patients with inborn errors of metabolism and the attitudes of their parents towards vaccines. Vaccine 2015;33:6520\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.073.","DOI":"10.1016\/j.vaccine.2015.10.073"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_018","doi-asserted-by":"crossref","unstructured":"Shteinberg, M, Haq, IJ, Polineni, D, Davies, JC. Cystic fibrosis. Lancet 2021;397:2195\u2013211. https:\/\/doi.org\/10.1016\/S0140-6736(20)32542-3.","DOI":"10.1016\/S0140-6736(20)32542-3"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_019","doi-asserted-by":"crossref","unstructured":"Saudubray, JM, Baumgartner, MR, editors. Inborn Metabolic Diseases: Diagnosis and Treatment, 6th ed. Berlin: Springer; 2016.","DOI":"10.1007\/978-3-662-49771-5"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_020","doi-asserted-by":"crossref","unstructured":"Zubarioglu, T, Oral-Cebeci, S, Hopurcuoglu, D, Uygur, E, Ahmadzada, S, Uzunyayla-Inci, G, et al.. Safety of COVID-19 vaccines in children with inborn errors of metabolism in terms of developing metabolic decompensation. J\u00a0Paediatr Child Health 2023;59:41\u20136. https:\/\/doi.org\/10.1111\/jpc.16231.","DOI":"10.1111\/jpc.16231"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_021","doi-asserted-by":"crossref","unstructured":"Morgan, TM, Schlegel, C, Edwards, KM, Welch-Burke, T, Zhu, Y, Sparks, R, et al.. Urea cycle disorders consortium. Vaccines are not associated with metabolic events in children with urea cycle disorders. Pediatrics 2011 127:e1147\u201353. https:\/\/doi.org\/10.1542\/peds.2010-1628.","DOI":"10.1542\/peds.2010-1628"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_022","doi-asserted-by":"crossref","unstructured":"Y\u0131lmazba\u015f, P, \u00c7akar, NE. Evaluation of vaccination status among children with inborn errors of metabolism. Med J Bak\u0131rk\u00f6y 2021;17:11\u20137.","DOI":"10.5222\/BMJ.2021.93723"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_023","doi-asserted-by":"crossref","unstructured":"Do, LAH, Mulholland, K. Measles 2025. N Engl J Med 2025;393:2447\u201358. https:\/\/doi.org\/10.1056\/NEJMra2504516.","DOI":"10.1056\/NEJMra2504516"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_024","doi-asserted-by":"crossref","unstructured":"Dinleyici, EC, Kurugol, Z, Devrim, I, Bayram, N, Dalgic, N, Yasa, O, et al.. VARICOMP study group. Pediatric varicella-related hospitalization in Turkey between 2008 and 2018: impact of universal single dose varicella vaccine (VARICOMP study). Pediatr Infect Dis J 2025;44:83\u20139. https:\/\/doi.org\/10.1097\/INF.0000000000004521.","DOI":"10.1097\/INF.0000000000004521"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_025","doi-asserted-by":"crossref","unstructured":"Wolfson, LJ, Daniels, VJ, Pillsbury, M, Kurug\u00f6l, Z, Yardimci, C, Kyle, J, et al.. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PLoS One 2019;14:e0220921. https:\/\/doi.org\/10.1371\/journal.pone.0220921.","DOI":"10.1371\/journal.pone.0220921"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_026","doi-asserted-by":"crossref","unstructured":"Shen, P, Xu, C, Li, T, Rui, Y, Hu, Y, Zhang, Y, et al.. Level of antibody to hepatitis B surface antigen declined below 10 mIU\/mL is still protective. NPJ Vaccines 2025;10:126. https:\/\/doi.org\/10.1038\/s41541-025-01188-9.","DOI":"10.1038\/s41541-025-01188-9"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_027","doi-asserted-by":"crossref","unstructured":"Dinleyici, M, Carman, KB, Kilic, O, Laciner Gurlevik, S, Yarar, C, Dinleyici, EC. The immunization status of children with chronic neurological disease and serological assessment of vaccine-preventable diseases. Hum Vaccin Immunother 2018;14:1970\u20136. https:\/\/doi.org\/10.1080\/21645515.2018.1460986.","DOI":"10.1080\/21645515.2018.1460986"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_028","doi-asserted-by":"crossref","unstructured":"Esposito, S, Salvini, F, Menni, F, Scala, A, Salvatici, E, Manzoni, F, et al.. Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation. Vaccine 2013;31:5149\u201351. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.058.","DOI":"10.1016\/j.vaccine.2013.08.058"},{"key":"2026070716574686928_j_jpem-2026-0016_ref_029","doi-asserted-by":"crossref","unstructured":"Dinleyici, EC, Borrow, R, Safadi, MAP, van Damme, P, Munoz, FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vaccin Immunother 2021;17:400\u20137. https:\/\/doi.org\/10.1080\/21645515.2020.1804776.","DOI":"10.1080\/21645515.2020.1804776"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0016\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0016\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:08:04Z","timestamp":1783444084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0016\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,7,24]]}},"alternative-id":["10.1515\/jpem-2026-0016"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2026-0016","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}